As a boutique consulting firm serving major pharmaceutical companies, V2’s founder wanted to build a formal sales platform to help reach new clients and aggressively scale the company’s growth. The company had relied on the client relationships developed by the PhD staff, and while business was steady, it wasn’t growing fast enough. The owner felt the company was capable of much wider market penetration and much greater success.
The 200% Company’s Lead Growth Consultant took on the role of VP of Business Development in order to build a successful growth initiative from the ground up. Within one year, the company had acquired nine new major pharmaceutical company clients, annual revenue more than doubled. V2 became an even more dominant player in its industry and continued on its growth trajectory. With such rapid revenue growth and an enviable list of new pharmaceutical clients, V2 was eventually sold to a global competitor for significantly greater value.